Linking diabetes to worsening knee osteoarthritis symptoms and disability: evidence from the osteoarthritis initiative
This longitudinal cohort study provides evidence supporting the association between baseline DM and increased knee symptoms and disability among individuals with knee OA.
Authors
- Bader Ali Alqahtani (ORCID: https://orcid.org/0000-0002-8275-6906)
- Mohammed S. Alghamdi (ORCID: https://orcid.org/0000-0002-4811-3632)
- Vishal S. Vennu (ORCID: https://orcid.org/0000-0001-7616-3955)
- Norah Alhwoaimel (ORCID: https://orcid.org/0000-0001-9448-4365)
- Sultan Mohammed Alanazi (ORCID: https://orcid.org/0009-0002-2411-0338)
- Yasir S. Alshehri (ORCID: https://orcid.org/0000-0003-0443-5514)
- Sattam Almutairi (ORCID: https://orcid.org/0000-0002-2282-7127)
- Saad M. Bindawas
- Ahmad D. Alanazi
- Abdullah M. Alqthami
- Sultan A. Alanazi
- Aqeel M. Alenazi
Institutions
- Prince Sattam Bin Abdulaziz University (SA)
- Qassim University (SA)
- Majmaah University (SA)
- Umm al-Qura University (SA)
- Taibah University (SA)
- King Saud University (SA)
- King Khaled Hospital (SA)
- Comprehensive Clinical Research (US)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2026-02-18
- DOI
- https://doi.org/10.3389/fmed.2026.1759342
- Primary Topic
- Osteoarthritis Treatment and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Health and Human Services
- Pfizer
- GlaxoSmithKline
- Novartis Pharmaceuticals Corporation
- Prince Sattam bin Abdulaziz University
- Majmaah University
- National Institutes of Health